|
Post by atomicpunk on Apr 29, 2016 2:07:47 GMT
Subretinal Transplantation of Embryonic Stem Cell–Derived Retinal Pigment Epithelium for the Treatment of Macular Degeneration: An Assessment at 4 Years Steven D. Schwartz; Gavin Tan; Hamid Hosseini; Aaron Nagiel iovs.arvojournals.org/article.aspx?articleid=2518369
|
|
|
Post by greatceasarsghost on May 31, 2016 20:40:53 GMT
So OCAT is gone and STEM is out of business. Damn sad. I remember a few years ago a friend told me "if stem cell were really the next big thing, something would have happened by now." How right he was. Do people still come here cuz:
|
|
|
Post by sheikyabooty on Jun 1, 2016 1:20:10 GMT
Smells dank and moldy on this message board, like a wet basement carpet.
|
|
|
Post by JHam on Jun 1, 2016 9:39:15 GMT
Smells dank and moldy on this message board, like a wet basement carpet. Yeah I noticed that as well right as you walked in. Back to give some more genius stock tips sheik?
|
|
|
Post by actcfan on Jun 1, 2016 13:26:29 GMT
Nobody goes to the OCAT section anymore, but plenty of activity in other forums here. Suggest you check them out, several interesting stock stories and none of them have Gary Rabin as CEO.
|
|
|
Post by greatceasarsghost on Jun 1, 2016 13:37:51 GMT
Nobody goes to the OCAT section anymore, but plenty of activity in other forums here. Suggest you check them out, several interesting stock stories and none of them have Gary Rabin as CEO. You know we can see the dates on the posts right?
|
|
|
Post by actcfan on Jun 1, 2016 13:55:47 GMT
Nobody goes to the OCAT section anymore, but plenty of activity in other forums here. Suggest you check them out, several interesting stock stories and none of them have Gary Rabin as CEO. You know we can see the dates on the posts right? So you can see I'm up 30% in two weeks on ADXS thanks to the forum here and fellow posters sharing due diligence? I remember a place that had a high volume of posts, don't remember much value being created though. You can get volume at Yahoo as well. I'll take quality over quantity any day.
|
|
|
Post by greatceasarsghost on Jun 1, 2016 14:11:00 GMT
You know we can see the dates on the posts right? So you can see I'm up 30% in two weeks on ADXS thanks to the forum here and fellow posters sharing due diligence? I remember a place that had a high volume of posts, don't remember much value being created though. You can get volume at Yahoo as well. I'll take quality over quantity any day. Hey man, Congrats on your ADXS trade.
|
|
|
Post by actcfan on Jun 1, 2016 14:33:52 GMT
Thanks, I hope many people here caught that trade as well.
|
|
|
Post by actcfan on Jun 1, 2016 17:52:14 GMT
I should also point out I've been completely wrong so far on ONCS the last two weeks..
|
|
|
Post by RLC on Jun 1, 2016 18:26:28 GMT
I should also point out I've been completely wrong so far on ONCS the last two weeks.. I wouldn't go that far. IMO, ONCS should be moving up at a faster pace than it is. The biotech sector has done quite well recently and we're getting much closer to ONCS's judgement day (Phase 2b data release). I'm starting to feel like the real threat isn't necessarily a loss, but rather capped gains in the near term. Similar to what we had to endure with LPC and ACTC/Ocata... the healthcare fund could just let the PPS ride to an acceptable level (likely breakeven or slightly above) and sell. I hope we are both dead wrong, as I'm still neck-deep in ONCS shares
|
|
|
Post by actcrazy on Jun 2, 2016 15:35:31 GMT
Anyone notice on 5-24-16 that Astelles sold their old Lupus program to Thunderbolt Pharma. I can think of a couple of reasons they sold that particular program. When the Delaware courts are through with the Ocata transaction, I wonder how long will Astelles wait before releasing Lanza's work??? I wonder if Thunderbolt knows of Astelles's new lupus/Lanza program?? Just something else for the pile. GLTA
|
|
|
Post by actcfan on Jun 2, 2016 16:13:25 GMT
Anyone notice on 5-24-16 that Astelles sold their old Lupus program to Thunderbolt Pharma. I can think of a couple of reasons they sold that particular program. When the Delaware courts are through with the Ocata transaction, I wonder how long will Astelles wait before releasing Lanza's work??? I wonder if Thunderbolt knows of Astelles's new lupus/Lanza program?? Just something else for the pile. GLTA Interesting, do you have a link related to the sale? I'm a little foggy on the details, what is the cliff notes version of the difference between the old and new lupus programs at OCAT? Thanks
|
|
|
Post by actcrazy on Jun 2, 2016 16:33:02 GMT
Found it on my etrade news feed dated 5-24 ...at work now ..not good with links.
|
|
|
Post by spangua on Jun 2, 2016 17:15:10 GMT
|
|
|
Post by sheikyabooty on Jun 3, 2016 0:25:28 GMT
Smells dank and moldy on this message board, like a wet basement carpet. Yeah I noticed that as well right as you walked in. Back to give some more genius stock tips sheik? I'm done with Biotech. Seen too many of them blow up in peoples faces. I actually want to retire comfortably one day so I'm now into dividend stocks and income replacement. Compounding dividends is how I get my kicks.
|
|
|
Post by greatceasarsghost on Jun 3, 2016 13:18:40 GMT
Yeah I noticed that as well right as you walked in. Back to give some more genius stock tips sheik? I'm done with Biotech. Seen too many of them blow up in peoples faces. I actually want to retire comfortably one day so I'm now into dividend stocks and income replacement. Compounding dividends is how I get my kicks. I heard dat. I rolled the OCAT money into financials. Rate hike coming (yeah, still with the horrible jobs number) and stress tests and possible dividend hikes. Had to do. Nobody got in to CPXX? Too bad.
|
|
|
Post by myocata on Jun 8, 2016 20:14:38 GMT
How's everyone here doing? I saw a bunch of "Completed" trial status as of June 2016. is and a forum for Astellas?
|
|
|
Post by JHam on Jun 9, 2016 7:27:59 GMT
How's everyone here doing? I saw a bunch of "Completed" trial status as of June 2016. is and a forum for Astellas? A forum as in, one here on the board to continue the discussion in?
|
|
|
Post by actcrazy on Jun 10, 2016 3:02:54 GMT
Wotton strikes again....ASX , CYP , Cynata Thereputics newest board member. The press talks him up for what he did with Ocat. The company is about MSC's and multiplying them.
|
|